Earnings

Twist Bioscience (TWST) Reports Q2 2026 Financial Results

Published on 5/10/2026

#TWST#Earnings#RevenueGrowth#SyntheticDNA
Twist Bioscience (TWST) Reports Q2 2026 Financial Results

AI Summary

Summarized by AI from the source below

Twist Bioscience Corporation (TWST) reported its financial results for Q2 2026. The company achieved revenue growth of 10% year-over-year, reaching $30 million. The gross profit margin for the quarter was reported at 65%. This performance indicates a steady demand for their synthetic DNA products, which could positively influence market confidence in TWST's future growth.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Cardinal Health Raises Price Target After Positive Profit Guidance
Earnings

Cardinal Health Raises Price Target After Positive Profit Guidance

Aug 11

Hnit-Baltic Uab Announcement: Financial Performance Updates
Earnings

Hnit-Baltic Uab Announcement: Financial Performance Updates

Aug 11

Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Earnings

Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments

Aug 11

Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth
Earnings

Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth

Aug 11